Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumours. (2017)
Attributed to:
OxCD3: Oxford Centre for Drug Delivery Devices
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s40349-017-0104-0
PubMed Identifier: 29118984
Publication URI: http://europepmc.org/abstract/MED/29118984
Type: Journal Article/Review
Volume: 5
Parent Publication: Journal of therapeutic ultrasound
ISSN: 2050-5736